Management References

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008. Allergy. 2008;63(Suppl. 86):8–160.

Bousquet J, Anto JM, Demoly P, Schünemann HJ, Togias A, Akdis M et al. Severe chronic allergic (and related) diseases: a uniform approach – a MeDALL – GA2LEN – ARIA position paper. Int Arch Allergy Immunol. 2012a;158:216–31.

Bousquet J, Schünemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW et al. MACVIA-ARIA Sentinal NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70:1372–92.

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–74.

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Begmann KC et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016a;6:47.

Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72(6):857-65.

Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62:17–25.

Ciammi D, Biaz N, Tanno LK, Demoly P, Arnavielhe S, Murray R, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526-33.

Demoly P, Calderon MA, Casale T, Scadding G, Annesi-Maesano I, Braun JJ et al. Assessment of disease control in allergic rhinitis. Clin Transl Allergy. 2013;3:7.

Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013a;43:881–8.

Derebery J, Meltzer E, Nathan RA, Stang PE, Campbell UB, Corrao M et al. Rhinitis symptoms and comorbidities in the United States: burden of rhinitis in America survey. Otolaryngol Head Neck Surg. 2008;139(2):198–205.

Ehrs PO, Åberg H, Larsson K. Quality of life in primary care asthma. Respir Med. 2001;95:22–30.

Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R. A comparison of healthcare resource utilisation and costs for patients with allergic rhinitis on single-product or free-combination therapy of intranasal steroids and intranasal antihistamines. J Manag Care Spec Pharm. 2016;22:1426–36.

Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. 2013;68:1–7.

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36.

Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire. J Allergy Clin Immunol. 1999;104,364–9.

Klimek L, Schendzielorz P. Early detection of allergic diseases in otorhinolaryngology. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008;7:Doc04.

Klimek L, Bergmann K-C, Biedermann T, Bousquet J, Hellings P, Jung K et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J Int. 2017;26:16–24.

Lohia S, Schlosser J, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569–79.

Magnen A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008;63:292–8.

Pedersen S. From asthma severity to control: a shift in clinical practice. Prim Care Respir J. 2010;19(1):3–9.

Price D, Kemp L, Sims E, von Ziegenweidt J, Navaratnam P, Lee AJ et al. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir J. 2010;19(3):266–73.

Rhinoconjunctivitis Quality of Life Questionnaire. Available at www.qoltech.co.uk/rqlq.html